NARG1 Polyclonal Antibody - BT-AP05782

NARG1 Polyclonal Antibody

Sizes: 20μL, 50μL, 100μL

Catalogue Numbers: BT-AP05782-20, BT-AP05782-50, BT-AP05782-100

Citations, Manuals and MSDS Available upon request.

Background: NAA15 is a Protein Coding gene. Auxillary subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Required to control retinal neovascularization in adult ocular endothelial cells. In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter. Diseases associated with NAA15 include n-terminal acetyltransferase deficiency and gastric cancer. Gene Ontology (GO) annotations related to this gene include poly(A) RNA binding and N-acetyltransferase activity. An important paralog of this gene is NAA16.

Research Areas: Epigenetics and Nuclear Signaling

Target Protein: NAA15

Applications: WB, IHC-p, IF, ELISA

Reactivity: Human, Mouse

Clonality: Polyclonal

Host: Rabbit

Isotype: IgG

Full Product Name: NARG1 Antibody

Immunogen: The antiserum was produced against synthesized peptide derived from human AMPK alpha around the phosphorylation site of Thr172. AA range:140-189

Storage: -20°C for 1 year

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration: 1 mg/ml

Molecular Weight (Da): 101272

UniProt Accession: Human: Q9BXJ9; Mouse: Q80UM3

Synonyms: NAA15; GA19; NARG1; NATH; TBDN100; N-alpha-acetyltransferase 15; NatA auxiliary subunit; Gastric cancer antigen Ga19; N-terminal acetyltransferase; NMDA receptor-regulated protein 1; Protein tubedown

GeneID: Human: 80155

Research Use Only